A preparation model of Chinese medicine decoction placebo

Li-qun Bian; Bao-shuang Li; Zhen-hua Li; Feng-yun Wang; Yan-dong Wen; Xu-dong Tang

doi:10.1007/s11655-016-2538-6

Your Location：

Home >

Browse articles >

A preparation model of Chinese medicine decoction placebo

OriginalPaper | Updated：2021-08-27

- A preparation model of Chinese medicine decoction placebo
- A preparation model of Chinese medicine decoction placebo
- 中国结合医学杂志（英文版） 2017年23卷第8期页码：631-634
- Affiliations：
  
  Department of Gastroenterology, Xiyuan Hospital, China Academy of Chinese Medical Sciences,Beijing,China
- Author bio：
- Funds：
  
  Support by National Key Technology R&D Program during the "Twelfth Five-year" Plan Period (No. 2013BAI02B05), Miaopu Program of Xiyuan Hospital of China Academy of Chinese Medical Sciences [No. XYKY-MP(2013)-7]
- DOI：10.1007/s11655-016-2538-6
  中图分类号：
- 纸质出版日期：2017，
  
  网络出版日期：2016-12-29，
Scan for full text
Bian, Lq., Li, Bs., Li, Zh. et al. A preparation model of Chinese medicine decoction placebo., Chin. J. Integr. Med. 23, 631–634 (2017). https://doi.org/10.1007/s11655-016-2538-6

Li-qun Bian, Bao-shuang Li, Zhen-hua Li, et al. A preparation model of Chinese medicine decoction placebo[J]. Chinese Journal of Integrative Medicine, 2017,23(8):631-634.
Bian, Lq., Li, Bs., Li, Zh. et al. A preparation model of Chinese medicine decoction placebo., Chin. J. Integr. Med. 23, 631–634 (2017). https://doi.org/10.1007/s11655-016-2538-6 DOI：

Li-qun Bian, Bao-shuang Li, Zhen-hua Li, et al. A preparation model of Chinese medicine decoction placebo[J]. Chinese Journal of Integrative Medicine, 2017,23(8):631-634. DOI： 10.1007/s11655-016-2538-6.

摘要

Chinese medicine (CM) decoction placebo is one of the key factors restricting the placebo-controlled clinical trial of CM. In this article

based on the analysis of the diffificulties in preparing CM placebo

the production requirements for placebo were put forward. Moreover

in accordance with clinical practices

a production method and evaluation process of CM decoction placebo was proposed

to provide a reference for clinical research.

Abstract

Chinese medicine (CM) decoction placebo is one of the key factors restricting the placebo-controlled clinical trial of CM. In this article

based on the analysis of the diffificulties in preparing CM placebo

the production requirements for placebo were put forward. Moreover

in accordance with clinical practices

a production method and evaluation process of CM decoction placebo was proposed

to provide a reference for clinical research.

关键词

PlacebodecoctionChinese Medicinepreparation model

Keywords

PlacebodecoctionChinese Medicinepreparation model

references

Wu SP, Xu LP, Guo Y, Cui YS, Zhao XY, Li Y, et al. Current application of placebo in Chinese clinical studies in past 30 years. China J Chin Mater Med (Chin) 2015;40:1410–1414.

Bi JF, Duan JG, Liu ZM. Discussion on the effect of placebo control in randomized controlled trials (RCTs). Pharmacol Clin Chin Mater Med (Chin)2007;23:59–61.

Wang YF, Ruan XM, Wu HL, Ou AH,Cao BJ, Mu QY, et al. Preparation of Chinese herbal medicine placebos and efficacy evaluation in large-scale double-blind clinical trails. Tradit Chin Drug Res Clin Pharmacol (Chin) 2011;22:255–258.

Wu J. Placebo control and clinical trial of Chinese medicine. J Chin Integr Med (Chin) 2010;8:906–910.

Liu JJ, Guo YM. Problems of TCM clinical trials. Progr in Jap Med (Chin) 2003;24:91–93.

Wang XF, Dong D, Liu F, Li Jie, Lu Ying. Exploration of placebo preparing in TCM clinical researches. Liaoning J Tradit Chin Med (Chin) 2003;30:966–967.

Tang XD, Bian LQ, Gao R, Guan SJ. Exploration into the preparation of placebos used in Chinese medicinal clinical trial. Chin J Integr Tradit West Med (Chin) 2009;29:656–658.

Lin M, Tang XD, Wang FY, Bian ZX, Yang JQ. Effects of low-concentration ’Chang An ?’ placebo on visceral hypersensitivity in diarrhea-predominant IBS rats. Shanghai J Tradit Chin Med (Chin) 2010;44:88–90.

Lin M, Tang XD, Wang FY. Pharmacodynamics study on Chang’an ? and control placebo containing low concentration original drug. Shenzhen J Integr Tradit Chin West Med (Chin) 2009;19:273–278.

Dai XB, Sun XM, Jiang PJ, Ni HW, Chen JY, Zhang WX. Modified Shengma Biejia decoction combined with CAG program for elderly acute myeloid leukemia patients with yin deficiency toxin stasis syndrome. Chin J Integr Tradit West Med (Chin) 2016;36:149–154.

Chen R, Zhou YF, Zhang ZY, Geng L, Lin SQ. Treatment for premenstrual syndrome with Vitex agnus castus: a prospective, randomised, plaeebo controlled, multicenter study in Chinese women. J Reprod Med (Chin) 2011;20:452–457.

Caroli A, Perico N, Perna A, Antiga L, Brambilla P, Pisani A, et al. Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial. Lancet 2013;382:1485–1495.

Lin XJ, Li R. Reflections into the latent contradictions between the "placebo" concept and traditional Chinese medicine. Chin Acupunct Moxibust (Chin) 2013;33:269–272.

FULL TEXT LINK

More>

浏览量

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Therapeutic Effect of Chang’an I Recipe (肠安 I 号方) on Irritable Bowel Syndrome with Diarrhea: A Multicenter Randomized Double-Blind Placebo-Controlled Clinical Trial

Future view and development of immunology: Exploring the immunology based on Chinese medicine and culture

Cost-effectiveness analysis of combined Chinese medicine and Western medicine for ischemic stroke patients

Objective tongue inspection on 142 liver cancer patients with damp-heat syndrome

Effect of Ermiao Recipe (二妙方) with medicinal guide Angelicae Pubescentis Radix on promoting the homing of bone marrow stem cells to treat cartilage damage in osteoarthritis rats